Coronary Artery Bypass Grafting Devices (CABG) Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029

Coronary artery bypass grafting (CABG) is a common treatment approach for coronary heart disease, which is one of the leading cause of death worldwide. Coronary artery disease occurs when oxygen rich blood flow to the heart muscle gets constricted owing to formation of blocking matter in the wall of coronary arteries and further cause heart attack or chest pain (angina). As per the records of the World Health Organization (WHO), coronary artery disease was responsible for 7.4 million death worldwide in the year 2019 and this global burden of cardiovascular disease is on rise due to sedentary lifestyle and smoking, high blood pressure and cholesterol for inappropriate diet habit, increasing prevalence of diabetes and obesity.

One of the common medical interventions for treating coronary artery disease include coronary artery bypass grafting (CABG). The procedure involves grafting of healthy artery or vein to the blocked part of coronary artery to normalize blood flow to heart. Minimal risk, excellent outcomes and improved long-term survival rates made CABG surgery the most preferred option for coronary artery disease treatment.

Coronary artery bypass grafting market is segmented on the basis of surgery performed: Off pump or beating-heart surgery where grafting is done in beating heart utilizing special equipment, on-pump or arrested-heart surgery where surgery is performed in stopped heart using a heart-lung machine to take over the function of blood circulation and minimally invasive direct coronary artery bypass grafting where small incision is made for bypassing the blood vessel. Depending on the technique followed for CABG procedure, the market is classified as traditional vessel harvesting and endoscopic vessel harvesting (EVH). EVH is set to take over the traditional procedure as a result of its cost effectiveness and successful results. On the basis of device types, the CABG market has been segmented as tissue stabilizers, heart positioners, refractors, cannulas, cardiopulmonary bypass machines, endoscopic vessel harvesting systems and others. The endoscopic vessel harvesting systems segment is on rise on account of their surging demand among surgeons as a result of successful outcomes with minimal complications.

The coronary artery bypass graft market is expected to experience substantial growth as a result of growing prevalence of coronary artery disease. Rising geriatric population fuels the growth of coronary artery bypass graft market by driving the prevalence of chronic diseases like high blood pressure or other cardiovascular disorders. Favorable reimbursement policies for improved medical treatment play an important role to drive the coronary artery bypass graft market. Moreover, the application of other percutaneous coronary interventions (PCI) such as angioplasty and other minimally invasive procedures have been replacing bypass surgery in many cases and hinder the growth of coronary artery bypass grafts market.

The report ‘Coronary Artery Bypass Grafting Devices Market - Growth, Future Prospects, and Competitive Analysis, 2021 - 2029’ provides detailed insights and in-depth analysis of market with prevailing trend to achieve global perspective of coronary artery bypass grafting devices market. This report comprises analysis of market dynamics including market drivers, restrains or market opportunities which allow industry experts to take business strategy. Major competitive landscape analysis of manufacturers with major partnerships, collaboration, mergers and acquisition activities of key players have been delivered in the study. Globally rising health concerns, increasing prevalence of chronic ailments and surging expenditure in research to develop new products boost the growth of coronary artery bypass grafting devices market. This report offers market size and forecast for every stated section with cross-sectional analysis for the duration of 2019-2029 along with corresponding CAGRs for forecast period 2021-2029.

Based on the geography, the coronary artery bypass grafting devices market is presented as five major areas which further are segmented as follow:

• North America
• The United States
• Canada
• Europe
• The United Kingdom
• Germany
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East and Africa
• Gulf Cooperation Council (GCC)
• Rest of Middle East and Africa

This research report contains brief description of major market players in the field of global coronary artery bypass grafting devices market and the players profiled in this report are Terumo Corporation, Medtronic, MAQUET Holding B.V. & Co.KG, Saphena Medical, Inc., Sorin Group, Vitalitec International, Inc., AtriCure, Inc., Edwards Lifesciences, Genesee Biomedical Inc., KARL STORZ GmbH & Co. KG, Transonic and others.

Based on devices deployed in coronary artery bypass grafts (CABG) surgical procedure, the market is categorized on the following basis:

• Tissue stabilizer
• Heart Positioner
• Refractor
• Cannula
• Cardiopulmonary Bypass Machines
• Endoscopic Vessel Harvesting System
• Others

Tissue stabilizers and heart positioners have a massive role in off pump coronary artery bypass grafts procedure to immobilize the heart. The preference for off pump CABG procedure high owing to clinical advantages, which increases the usage of tissue stabilizers and heart positioners in order to accomplish successful treatment. The market of coronary artery bypass grafts is rising with the increasing usage of endoscopic vessel harvesting systems in bypass grafting procedure. With the recent advancement of technology, scopes of risks and complications have reduced, while using endoscopic vessel harvesting systems in surgeries making these devices more preferred among surgeons. During on pump coronary artery bypass grafting, cardiopulmonary bypass machine is used to take over the function of heart and lung. These devices are currently experiencing huge demand on account of high number of on pump coronary artery bypass grafts procedures in medical facilities. However, its demand is expected to get diminished in coming years due to associated risk and infections.

On the basis of surgical procedures, coronary artery bypass grafting devices market is categorized on the following basis:

• On-Pump or Traditional Coronary Artery Bypass Grafting
• Off -Pump Coronary Artery Bypass Grafting
• Minimally Invasive Direct Coronary Artery Bypass Grafting

On-pump or traditional coronary artery bypass grafting is the predominant segment where chest is opened to gain access for intervention and heart-lung machine is attached for blood and oxygen flow. More familiarity with this procedure among surgeons makes it the leading segment and preferred procedure. On-pump coronary artery bypass grafts avoids repeat revascularization, which subsequently raised its demand among medical professionals. Increasing number of cardiac emergencies rises the usage of on-pump coronary artery bypass grafting in healthcare facilities.

The market share of off pump bypass grafts is on rise owing to minor chances of risk and infection and avoids morbidity as it is performed without usage of any heart-lung machine. Off-pump bypass grafting shows significant benefits such as shorter recovery time than traditional coronary artery bypass grafting, minimal blood loss, reduced inflammatory response, and lower postoperative complications. Lower morbidity and mortality rate associated to off-pump CABG procedure increases its demand.

Minimally invasive coronary artery bypass grafting is an alternative of traditional coronary bypass artery grafts where small incision is made to gain access to coronary arteries which need to get grafted. The rising demand of this procedure is due to lower risk of infection and complication, minimal scar and increasing patient satisfaction. However, minimally invasive coronary artery bypass grafting is not suitable for multiple diseased vessel and this limitation might hinder the growth of minimally invasive direct coronary artery bypass grafting.

Based on the technique followed, coronary artery bypass grafting devices market is classified on the following basis:

• Traditional Vessel Harvesting
• Endoscopic Vessel Harvesting (EVH)

In traditional vessel harvesting, a longer incision is made for removal of vessel to be used for bypass grafting and it leaves extended scar and further wound complications. Traditional vessel harvesting is expected to lose its market share due to increasing demand of endoscopic vessel harvesting (EVH) technique. Endoscopic vessel harvesting is likely to gain considerable acceptance in coming years as a result of minimal complication like infections, scar and hematoma formation, lesser leg wounds and shorter recovery time. In the United States, around 80% coronary artery bypass grafts are performed using EVH technique. In EVH procedure, a smaller incision is made to remove blood vessel using surgical and video equipment. Endoscopic vessel harvesting is anticipated to take over the coronary artery bypass grafting devices market in future due to overall lower medical cost, shorter hospital stay and successful results. The advantage of quick focus on cardiac rehabilitation after bypass grafting, more patient satisfaction and lesser post-operative pain are few driving factors of endoscopic vessel harvesting procedures.

Geographically, the global coronary artery bypass grafting devices market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is estimated to lead the coronary artery bypass grafting devices market with maximum revenue followed by Europe. According to the data of American Heart Association, heart disease is the leading cause of death in the United States where coronary heart disease alone is responsible for killing more than 360,000 people in a year. By the year 2021, the medical cost regarding coronary heart disease was US $ 10.4 Bn which is projected to increase in future years by 100%, and this increasing trend supports the considerable growth of coronary artery bypass grafting devices market in North America. Coronary artery bypass grafting is a commonly performed procedure in the United States with nearly 400,000 procedures per year. The American Heart Association has committed to fund 980 new research projects worth $163 million and this increasing research expenditure is also driving the growth of coronary artery bypass grafting devices market in the United States. Moreover, increasing geriatric population, growing chronic cardiac disorder, rising prevalence of high blood pressure and diabetes are few key factors propelling the growth of coronary artery bypass grafting devices market in this region. As per the record of British Heart Foundation, more than 2.3 million people are suffering from coronary heart diseases in the United Kingdom and this number is on rise due to sedentary lifestyle and smoking habits in Europe region.

Asia Pacific is projected to witness lucrative growth in coming years on account of rising elderly population, increasing prevalence of hypertension, obesity and diabetes which further leads to coronary artery disorders.

The detailed regional classification of the global coronary artery bypass grafting devices market is as follows:

• North America (Canada and The United States)
• Europe (The United Kingdom, Germany and Rest of Europe)
• Asia Pacific (Japan, China, India and Rest of Asia Pacific)
• Latin America (Mexico, Brazil and Rest of Latin America)
• Middle East and Africa (GCC and rest of Middle East and Africa)

This product will be delivered within 2 business days.